Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer

Journal of Infectious Diseases

Volumn 187, Issue 7, 2003, Pages 1147-1152

  Ness, Roberta B ^a,d   Goodman, Marc T ^b   Shen, Caixia ^c   Brunham, Robert C ^c  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^c BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 10; HEAT SHOCK PROTEIN 60; IMMUNOGLOBULIN G ANTIBODY; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; SEROTYPE; UNITED STATES;

ADULT; AGED; ANTIBODIES, BACTERIAL; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; OVARIAN NEOPLASMS; RISK FACTORS;

EID: 0037385131     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/368380     Document Type: Article

References (15)

1. Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 1999; 91:1459-57.
2. Cohen CR, Brunham RC. Pathogenesis of chlamydia induced pelvic inflammatory disease. Sex Transm Infect 1999; 75:21-4.
3. Shu XO, Gao YT, Yuan JM et al. Dietary factors and epithelial ovarian cancer. Br J Cancer 1989;59:92-6.
4. Risch HA, Howe GR. Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 1995; 4:447-51.
5. Ness RB, Grisso JA, Cottreau C, et al. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology 2000; 11:111-7.
6. Westrom L, Eschenback D. Pelvic inflammatory disease. In: Holmes KK, Sparling PG, Mardh P-A, et al. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill, 1999:783-810.
7. Goodman MT, McDuffie K, Kolonel LN, et al. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer Epidemiol Biomarkers Prev 2001; 10:209-16.
8. Aral SO, Mosher WD, Cates W. Self-reported pelvic inflammatory disease in the United States, 1988. JAMA 1991; 266:2570-3.
9. Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980; 138:880-92.
10. Cates W, Wasserheit JN. Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991; 164:1771-81.
11. Peeling RW, Patton DL, Cosgrove Sweeney YT, et al. Antibody response to the chlamydial heat-shock protein 60 in an experimental model of chronic pelvic inflammatory disease in monkeys. J Infect Dis 1999; 180:774-9.
12. Peeling RW, Kimani J, Plummer F, et al. Antibody to chlamydial hsp60 predicts an increased risk for chlamydial pelvic inflammatory disease. J Infect Dis 1997; 175:1153-8.
13. Witkin SS, Askienazy-Elbhar M, Henry-Suchet J, et al. Circulating antibodies to a conserved epitope of the Chlamydia trachomatis 60 kDa heat shock protein (hsp60) in infertile couples and its relationship to antibodies to C. trachomatis surface antigens and the Escherichia coli and human HSP60. Hum Reprod 1998; 13:1175-9.
14. Spandorfer SD, Neuer A, LaVerda D, et al. Previously undetected Chlamydia trachomatis infection, immunity to heat shock infection, immunity to heat shock proteins and tubal occlusion in women undergoing in-vitro fertilization. Hum Reprod 1999; 14:60-4.
15. Betsou F, Sueur JM, Orfila J. Serological investigation of Chlamydia trachomatis heat shock protein 10. Infect Immun 1999;67:5243-6.